32.73
+0(+0.00%)
Currency In USD
| Previous Close | 32.73 |
| Open | 32.74 |
| Day High | 32.98 |
| Day Low | 32.46 |
| 52-Week High | 34.24 |
| 52-Week Low | 9.22 |
| Volume | 646,348 |
| Average Volume | 868,401 |
| Market Cap | 1.5B |
| PE | -654.6 |
| EPS | -0.05 |
| Moving Average 50 Days | 26.78 |
| Moving Average 200 Days | 17.49 |
| Change | 0 |
If you invested $1000 in AxoGen, Inc. (AXGN) 10 years ago, it would be worth $6,481.19 as of January 02, 2026 at a share price of $32.73. Whereas If you bought $1000 worth of AxoGen, Inc. (AXGN) shares 5 years ago, it would be worth $1,869.22 as of January 02, 2026 at a share price of $32.73.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference
GlobeNewswire Inc.
Dec 17, 2025 12:00 PM GMT
ALACHUA, Fla. and TAMPA, Fla., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that the compa
Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx)
GlobeNewswire Inc.
Dec 04, 2025 1:01 AM GMT
ALACHUA, Fla. and TAMPA, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical technologies for the restoration of peripheral nerve function, today announced that the U.
Axogen, Inc. to Report 2025 Third Quarter Financial Results on October 29, 2025
GlobeNewswire Inc.
Oct 15, 2025 11:00 AM GMT
ALACHUA, Fla. and TAMPA, Fla., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that it will r